UPB

NASDAQ open

Upstream Bio

2.02 USD
▲+0.02+1.00%
盘后 3.50 0.00%
2026-11-20
市值
$87.15M
市盈率
—
EPS
-3.01
股息率
—
52 周区间
1.98 – 33.68
成交量
29.75K
Beta
1.61
目标价
21.40
52W 低 1.9852W 高 33.68
价格走势

公司简介

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.